Evidence map›Paper›PMID 42145806›Full record

ArticleJAC-antimicrobial resistance2026

Hongjian Ou, Yang Yang, Siquan Shen, Li Ding, Dandan Yin, Renru Han, Fupin Hu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JAC-antimicrobial resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hongjian OuInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.ORCID https://orcid.org/0009-0009-9171-8280
Yang YangInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Siquan ShenInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Li DingInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.ORCID https://orcid.org/0009-0001-1436-3668
Dandan YinInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Renru HanInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Fupin HuInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: This study comprehensively evaluates the Methods: A total of 1250 non-duplicate clinical isolates representing 12 genera and 21 species were collected from 40 hospitals between 2017 and 2019 across China. Minimal inhibitory concentrations were determined using the broth microdilution method in accordance with the standards set by the Clinical and Laboratory Standards Institute. Results: Eravacycline demonstrated potent Conclusions: This large-scale multicentre surveillance study demonstrated that eravacycline exhibited potent

Identifiers

PMID42145806
PMCPMC13179740

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.